Oncotarget

Vol 9, No 99

December 18, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 99 of Oncotarget features Figure 1C, "Schematic representation of atuveciclib mode of action," by Brisard, et al.

Table of Contents

News

Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma

Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma

https://doi.org/10.18632/oncotarget.26465

Kelly M. Bailey
37270-37271
PDF  |  How to cite  |  Order a Reprint

Sequence variation in the microRNA region of a cancer virus

Sequence variation in the microRNA region of a cancer virus

https://doi.org/10.18632/oncotarget.26471

Joseph M. Ziegelbauer
37272-37273
PDF  |  How to cite  |  Order a Reprint

Editorial

Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma

Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma

https://doi.org/10.18632/oncotarget.26403

Javier Vaquero, Cindy Lobe,  and Laura Fouassier
37274-37275
PDF  |  How to cite  |  Order a Reprint

Battling quiescence for tumor eradication: too good to be true?

Battling quiescence for tumor eradication: too good to be true?

https://doi.org/10.18632/oncotarget.26452

Nami McCarty
37276-37277
PDF  |  How to cite  |  Order a Reprint

Revisiting entinostat as an immune-potentiating adjuvant

Revisiting entinostat as an immune-potentiating adjuvant

https://doi.org/10.18632/oncotarget.26453

Tyler R. McCaw, Troy D. Randall,  and Rebecca C. Arend
37278-37279
PDF  |  How to cite  |  Order a Reprint

Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?

Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?

https://doi.org/10.18632/oncotarget.26460

Toby A. Eyre
37280-37281
PDF  |  How to cite  |  Order a Reprint

Exosomal transmission between macrophages and cancer cells: new insights to stroma-mediated drug resistance

Exosomal transmission between macrophages and cancer cells: new insights to stroma-mediated drug resistance

https://doi.org/10.18632/oncotarget.26463

Ziv Gil
37282-37283
PDF  |  How to cite  |  Order a Reprint

Reversing resistance to antiandrogens with a histone deacetylase inhibitor

Reversing resistance to antiandrogens with a histone deacetylase inhibitor

https://doi.org/10.18632/oncotarget.26464

Anna C. Ferrari
37284-37285
PDF  |  How to cite  |  Order a Reprint

Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins

Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins

https://doi.org/10.18632/oncotarget.26466

Yves Pommier, Mark Cushman,  and James H. Doroshow
37286-37288
PDF  |  How to cite  |  Order a Reprint

Cell-surface GPNMB and induction of stemness

Cell-surface GPNMB and induction of stemness

https://doi.org/10.18632/oncotarget.26472

Yukari Okita, Chen Chen,  and Mitsuyasu Kato
37289-37290
PDF  |  How to cite  |  Order a Reprint

Research Papers

Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas

Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas

https://doi.org/10.18632/oncotarget.26458

Ciro Soares, Thayná Melo de Lima Morais, Roman Carlos, Fernanda Viviane Mariano, Albina Altemani, Maria Goretti Freire de Carvalho, Marcelo Brum Corrêa, Rodrigo Ribas Dias dos Reis, Luciana Schultz Amorim, Oslei Paes de Almeida,  and Jacks Jorge
37291-37304
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer

Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer

https://doi.org/10.18632/oncotarget.26468

Daphne Brisard, Frank Eckerdt, Lindsey A. Marsh, Gavin T. Blyth, Sarika Jain, Massimo Cristofanilli, Dai Horiuchi,  and Leonidas C. Platanias
37305-37318
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment

https://doi.org/10.18632/oncotarget.26470

Abdul Khalid Siraj, Poyil Pratheeshkumar, Sandeep Kumar Parvathareddy, Sasidharan Padmaja Divya, Fouad Al-Dayel, Asma Tulbah, Dahish Ajarim,  and Khawla S. Al-Kuraya
37319-37332
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model

Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model

https://doi.org/10.18632/oncotarget.26484

Thinzar M. Lwin, Kentaro Miyake, Takashi Murakami, Jonathan C. DeLong, Siamak Amirfakhri, Filemoni Filemoni, Sang Nam Yoon, Paul J. Yazaki, John E. Shivley, Brian Datnow, Bryan M. Clary, Robert M. Hoffman,  and Michael Bouvet
37333-37342
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation

Correction: Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation

https://doi.org/10.18632/oncotarget.26504

Mengmeng Cheng, Shurong Hu, Zhengting Wang, Yaofei Pei, Rong Fan, Xiqiang Liu, Lei Wang, Jie Zhou, Sichang Zheng, Tianyu Zhang, Yun Lin, Maochen Zhang, Ran Tao,  and Jie Zhong
37343-37343
Correction  |  PDF  |  How to cite

Correction: PreImplantation factor (PIF) protects cultured embryos against oxidative stress: relevance for recurrent pregnancy loss (RPL) therapy

Correction: PreImplantation factor (PIF) protects cultured embryos against oxidative stress: relevance for recurrent pregnancy loss (RPL) therapy

https://doi.org/10.18632/oncotarget.26505

Lindsay F. Goodale, Soren Hayrabedyan, Krassimira Todorova, Roumen Roussev, Sivakumar Ramu, Christopher Stamatkin, Carolyn B. Coulam, Eytan R. Barnea,  and Robert O. Gilbert
37344-37344
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC